Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Liabilities and Shareholders Equity (2022 - 2025)

Historic Liabilities and Shareholders Equity for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $11.5 million.

  • bioAffinity Technologies' Liabilities and Shareholders Equity rose 7622.63% to $11.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.4 million, marking a year-over-year decrease of 380.23%. This contributed to the annual value of $6.5 million for FY2024, which is 2077.33% down from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Liabilities and Shareholders Equity is $11.5 million, which was up 7622.63% from $4.8 million recorded in Q2 2025.
  • bioAffinity Technologies' Liabilities and Shareholders Equity's 5-year high stood at $14.1 million during Q3 2022, with a 5-year trough of $4.8 million in Q2 2025.
  • Over the past 4 years, bioAffinity Technologies' median Liabilities and Shareholders Equity value was $8.2 million (recorded in 2023), while the average stood at $8.7 million.
  • As far as peak fluctuations go, bioAffinity Technologies' Liabilities and Shareholders Equity crashed by 3569.81% in 2024, and later skyrocketed by 7622.63% in 2025.
  • bioAffinity Technologies' Liabilities and Shareholders Equity (Quarter) stood at $12.2 million in 2022, then plummeted by 32.51% to $8.2 million in 2023, then decreased by 20.77% to $6.5 million in 2024, then skyrocketed by 77.26% to $11.5 million in 2025.
  • Its last three reported values are $11.5 million in Q3 2025, $4.8 million for Q2 2025, and $5.5 million during Q1 2025.